Precocious puberty

Summary

Precocious puberty is an early onset of puberty that can result from both central (functional) and peripheral (hormonal) causes. Early diagnosis and appropriate therapy, such as the administration of GnRH analogs, are essential to slow the progression of puberty and preserve growth potential. Treatment should be individualized based on the underlying cause and the child’s age, with close medical monitoring.

Pubertas praecox refers to the onset of puberty in girls before the age of 8 years. It is characterized by the premature appearance of secondary sexual characteristics, such as breast development, pubic hair, growth spurts, and sometimes menarche (first menstruation).

Precocious puberty is classified into two types:

  1. Central (true) precocious puberty:
    The hypothalamic-pituitary-gonadal axis is activated too early, leading to a true form of puberty caused by premature activation of the central hormonal control system.
  2. Peripheral precocious puberty:
    Puberty is triggered by autonomous hormone production outside the hypothalamic-pituitary-gonadal axis.

Causes of Precocious Puberty

Central (True) Precocious Puberty:

This is the most common form, where normal hormonal control is activated prematurely. Common causes include:

  1. Idiopathic (unknown cause):
    • In up to 90% of cases, no underlying disease or anomaly can be identified.
  2. Central Nervous System Tumors:
    • Examples include hamartomas (benign hypothalamic tumors), gliomas, craniopharyngiomas, and other brain tumors affecting the hypothalamus.
  3. Brain Injury or Inflammation:
    • Infections (e.g., meningitis, encephalitis), radiation therapy, or brain trauma can damage the hypothalamic-pituitary axis.
  4. Hydrocephalus or Neurological Anomalies:
    • Increased intracranial pressure or structural abnormalities can affect hypothalamic activation.
  5. Genetic Causes:
    • Genetic factors may play a role, especially when there is a family history of early puberty.

Peripheral Precocious Puberty:

This form occurs due to hormone production independent of central stimulation:

  1. Hormone-Producing Tumors:
    • Ovarian tumors (e.g., granulosa cell tumors) or adrenal tumors can produce estrogens or other hormones, triggering puberty.
  2. Congenital Adrenal Hyperplasia (CAH):
    • An overactive adrenal cortex produces excessive androgens, leading to premature development.
  3. McCune-Albright Syndrome:
    • A rare genetic disorder where tissues autonomously produce hormones, causing precocious puberty. Other features include bone dysplasia and café-au-lait spots (pigmented skin patches).
  4. Exogenous Hormone Exposure:
    • Use of hormonal medications or exposure to hormones (e.g., in cosmetics) can induce early puberty.

Symptoms of Precocious Puberty

Typical signs of precocious puberty in girls include:

  • Breast development (thelarche)
  • Pubic and axillary hair (pubarche)
  • Accelerated growth and growth spurts
  • Early menarche (first menstruation)
  • Adult body odor
  • Acne and oily skin
  • Emotional and social changes, similar to typical puberty (e.g., mood swings)

Diagnosis of Precocious Puberty

The diagnosis involves careful clinical evaluation and laboratory testing to differentiate between central and peripheral causes and rule out underlying conditions.

  1. Medical History and Physical Examination:
    • Document the onset and progression of puberty signs, growth patterns, and family history of puberty onset.
    • Assess secondary sexual characteristics.
  2. Hormone Analysis:
    • Gonadotropins (LH, FSH): Elevated or inappropriate LH and FSH levels (especially after a GnRH stimulation test) suggest central precocious puberty.
    • Estradiol: Elevated levels indicate ovarian activity.
    • Androgens: Measure DHEA-S and testosterone to check for adrenal involvement.
  3. Bone Age Assessment:
    • A hand X-ray evaluates bone age, which is usually advanced compared to chronological age in precocious puberty.
  4. Imaging:
    • Brain MRI: To detect structural abnormalities or tumors in the hypothalamus or pituitary gland.
    • Ultrasound of the ovaries and adrenal glands: To identify hormone-producing tumors.
  5. GnRH Test:
    • A GnRH stimulation test measures the pituitary response. A significant increase in LH and FSH after GnRH administration indicates central precocious puberty.

Treatment of Precocious Puberty

Treatment depends on the type of precocious puberty and focuses on slowing its progression, preserving growth potential, and addressing underlying causes.

Central Precocious Puberty:

  1. GnRH Analogs:
    • Standard therapy involves GnRH agonists (e.g., leuprolide, triptorelin), which suppress the premature release of LH and FSH, slowing down pubertal development.
    • Therapy continues until the child reaches the normal age for puberty to ensure proper development.
  2. Treatment of Underlying Causes:
    • If a tumor or other cause is identified, appropriate treatment (e.g., surgery) is required.

Peripheral Precocious Puberty:

  1. Treatment of Hormone-Producing Tumors:
    • Surgical removal of ovarian or adrenal tumors.
  2. Medical Therapy:
    • Medications to regulate hormone production in conditions like McCune-Albright syndrome or congenital adrenal hyperplasia.
  3. Elimination of Exogenous Hormone Exposure:
    • Identify and remove external sources of hormone exposure (e.g., medications or cosmetics).

Long-Term Monitoring

Girls with precocious puberty require long-term monitoring to track growth, bone age, and pubertal development. Psychosocial support is also important, as early puberty can present emotional and social challenges.